Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
936 | 10991 | 45.8 | 91% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
304 | 3 | P53//RETINOBLASTOMA//MDM2 | 40663 |
936 | 2 | P53//MDM2//P73 | 10991 |
1581 | 1 | P53//P53 GENE//ONCOGENE | 2584 |
1860 | 1 | MDM2//MDMX//MDM4 | 2454 |
4381 | 1 | P73//P63//EEC SYNDROME | 1795 |
8010 | 1 | MUTANT P53//PRIMA 1//CP 31398 | 1303 |
9053 | 1 | P53 POLYMORPHISM//P53 CODON 72//CODON 72 | 1191 |
13947 | 1 | P53//AREA BIOPATOL//BCL 2 | 803 |
19114 | 1 | LI FRAUMENI SYNDROME//LI FRAUMENI//GERMLINE TP53 MUTATION | 521 |
29487 | 1 | PINK EYED UNSTABLE//RADIAT ON AB MOL CELLULAR RADIAT BIOL//3 5 EXONUCLEASE | 185 |
31291 | 1 | IASPP//ASPP2//53BP2 | 155 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | P53 | authKW | 1326543 | 27% | 16% | 2940 |
2 | MDM2 | authKW | 1148862 | 7% | 51% | 815 |
3 | P73 | authKW | 847662 | 4% | 70% | 439 |
4 | P63 | authKW | 512020 | 4% | 44% | 417 |
5 | MDMX | authKW | 287433 | 1% | 93% | 111 |
6 | LI FRAUMENI SYNDROME | authKW | 277581 | 1% | 68% | 148 |
7 | MUTANT P53 | authKW | 210124 | 1% | 60% | 127 |
8 | TP53 | authKW | 162639 | 2% | 23% | 256 |
9 | MDM4 | authKW | 153836 | 1% | 83% | 67 |
10 | NUTLIN 3 | authKW | 134487 | 1% | 65% | 74 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Oncology | 70565 | 42% | 1% | 4595 |
2 | Cell Biology | 35822 | 30% | 0% | 3298 |
3 | Biochemistry & Molecular Biology | 15653 | 34% | 0% | 3686 |
4 | Genetics & Heredity | 13091 | 15% | 0% | 1694 |
5 | Pathology | 2226 | 5% | 0% | 516 |
6 | Biophysics | 657 | 4% | 0% | 433 |
7 | Hematology | 525 | 3% | 0% | 324 |
8 | Medicine, Research & Experimental | 365 | 3% | 0% | 372 |
9 | Developmental Biology | 302 | 1% | 0% | 158 |
10 | Dermatology | 151 | 1% | 0% | 158 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | P53 | 56872 | 0% | 50% | 41 |
2 | TRANSCRIPT NETWORKS | 37086 | 0% | 64% | 21 |
3 | TOXICOL UNIT | 28247 | 1% | 8% | 128 |
4 | IDI IRCCS | 28232 | 0% | 36% | 28 |
5 | BIOCHEM IDI IRCCS | 19191 | 0% | 43% | 16 |
6 | GRP MOL CARCINOGENESIS | 16646 | 0% | 50% | 12 |
7 | COMPARAT ONCOL | 16281 | 0% | 24% | 24 |
8 | SURG MOL ONCOL | 15486 | 0% | 14% | 41 |
9 | CHROMOSOME STABIL GRP | 14594 | 0% | 48% | 11 |
10 | MOL ONCOGENESIS | 12002 | 0% | 16% | 27 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ONCOGENE | 91545 | 7% | 4% | 774 |
2 | COLD SPRING HARBOR SYMPOSIA ON QUANTITATIVE BIOLOGY SERIES | 25712 | 2% | 4% | 215 |
3 | CELL DEATH AND DIFFERENTIATION | 15307 | 1% | 4% | 133 |
4 | CANCER RESEARCH | 7331 | 3% | 1% | 332 |
5 | INTERNATIONAL JOURNAL OF ONCOLOGY | 7291 | 1% | 2% | 161 |
6 | MOLECULAR AND CELLULAR BIOLOGY | 6977 | 2% | 1% | 243 |
7 | MOLECULAR CARCINOGENESIS | 5068 | 1% | 3% | 72 |
8 | BRITISH JOURNAL OF CANCER | 3556 | 1% | 1% | 157 |
9 | ONCOTARGET | 3543 | 1% | 1% | 129 |
10 | CELL DEATH & DISEASE | 3463 | 1% | 2% | 55 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | P53 | 1326543 | 27% | 16% | 2940 | Search P53 | Search P53 |
2 | MDM2 | 1148862 | 7% | 51% | 815 | Search MDM2 | Search MDM2 |
3 | P73 | 847662 | 4% | 70% | 439 | Search P73 | Search P73 |
4 | P63 | 512020 | 4% | 44% | 417 | Search P63 | Search P63 |
5 | MDMX | 287433 | 1% | 93% | 111 | Search MDMX | Search MDMX |
6 | LI FRAUMENI SYNDROME | 277581 | 1% | 68% | 148 | Search LI+FRAUMENI+SYNDROME | Search LI+FRAUMENI+SYNDROME |
7 | MUTANT P53 | 210124 | 1% | 60% | 127 | Search MUTANT+P53 | Search MUTANT+P53 |
8 | TP53 | 162639 | 2% | 23% | 256 | Search TP53 | Search TP53 |
9 | MDM4 | 153836 | 1% | 83% | 67 | Search MDM4 | Search MDM4 |
10 | NUTLIN 3 | 134487 | 1% | 65% | 74 | Search NUTLIN+3 | Search NUTLIN+3 |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | FREED-PASTOR, WA , PRIVES, C , (2012) MUTANT P53: ONE NAME, MANY PROTEINS.GENES & DEVELOPMENT. VOL. 26. ISSUE 12. P. 1268 -1286 | 157 | 81% | 263 |
2 | MULLER, PAJ , VOUSDEN, KH , (2014) MUTANT P53 IN CANCER: NEW FUNCTIONS AND THERAPEUTIC OPPORTUNITIES.CANCER CELL. VOL. 25. ISSUE 3. P. 304-317 | 124 | 77% | 206 |
3 | KARNI-SCHMIDT, O , LOKSHIN, M , PRIVES, C , (2016) THE ROLES OF MDM2 AND MDMX IN CANCER.ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 11. VOL. 11. ISSUE . P. 617 -644 | 165 | 83% | 6 |
4 | MEEK, DW , (2015) REGULATION OF THE P53 RESPONSE AND ITS RELATIONSHIP TO CANCER.BIOCHEMICAL JOURNAL. VOL. 469. ISSUE . P. 325 -346 | 182 | 66% | 45 |
5 | MULLER, PAJ , VOUSDEN, KH , (2013) P53 MUTATIONS IN CANCER.NATURE CELL BIOLOGY. VOL. 15. ISSUE 1. P. 2-8 | 89 | 93% | 386 |
6 | KO, LJ , PRIVES, C , (1996) P53: PUZZLE AND PARADIGM.GENES & DEVELOPMENT. VOL. 10. ISSUE 9. P. 1054-1072 | 160 | 68% | 1985 |
7 | WADE, M , LI, YC , WAHL, GM , (2013) MDM2, MDMX AND P53 IN ONCOGENESIS AND CANCER THERAPY.NATURE REVIEWS CANCER. VOL. 13. ISSUE 2. P. 83-96 | 121 | 71% | 283 |
8 | OZBUN, MA , BUTEL, JS , (1995) TUMOR-SUPPRESSOR P53 MUTATIONS AND BREAST-CANCER - A CRITICAL ANALYSIS.ADVANCES IN CANCER RESEARCH, VOL 66. VOL. 66. ISSUE . P. 71-141 | 319 | 79% | 95 |
9 | HOE, KK , VERMA, CS , LANE, DP , (2014) DRUGGING THE P53 PATHWAY: UNDERSTANDING THE ROUTE TO CLINICAL EFFICACY.NATURE REVIEWS DRUG DISCOVERY. VOL. 13. ISSUE 3. P. 217 -236 | 158 | 69% | 58 |
10 | NAG, S , ZHANG, X , SRIVENUGOPAL, KS , WANG, MH , WANG, W , ZHANG, R , (2014) TARGETING MDM2-P53 INTERACTION FOR CANCER THERAPY: ARE WE THERE YET?.CURRENT MEDICINAL CHEMISTRY. VOL. 21. ISSUE 5. P. 553 -574 | 196 | 66% | 25 |
Classes with closest relation at Level 2 |
Rank | Class id | link |
---|---|---|
1 | 483 | CYCLIN DEPENDENT KINASE//CELL CYCLE//CDK5 |
2 | 2913 | CELLULAR SENESCENCE//SENESCENCE//ST PETERSBURG BIOREGULAT GERONTOL |
3 | 2853 | RETINOBLASTOMA//OPHTHALM ONCOL SERV//CHEMOREDUCTION |
4 | 3037 | KLF4//KRUPPEL LIKE FACTOR//GADD45 |
5 | 306 | TRAIL//SURVIVIN//APOPTOSIS |
6 | 2606 | FHIT//WWOX//FRAGILE SITES |
7 | 2754 | MYC//MAX//C MYC |
8 | 3177 | PROTEIN KINASE CK2//CK2//CASEIN KINASE 2 |
9 | 3713 | A20//LAPTM4B//WWP1 |
10 | 900 | BRCA1//BRCA2//FANCONI ANEMIA |